Keyword: Heptares Therapeutics
Tokyo-based Sosei is looking to bolster its U.K. biotech reach after making an equity investment in MiNA, with an option tagged on to buy the private RNA company if its early-stage work goes well.
In this week's EuroBiotech Report, Cell Medica raises £60 million, Astex pockets Novartis milestone, Galapagos pens combination pact and more.
Heptares Therapeutics has struck a pain drug R&D pact with Daiichi Sankyo.
Heptares Therapeutics has teamed up with the University of Cambridge to discover molecules that modulate a cardiovascular target.
South San Francisco’s I/O biotech Ab Initio has penned a deal with Big Pharma Pfizer that will help fund the fledging company’s platform expansion.
Heptares Therapeutics is set to buy fellow European G protein-coupled receptor specialist G7 Therapeutics.